[Skip to Navigation]
Sign In
Views 275
Citations 0
Comment & Response
October 2018

Risk of Breast Implant–Associated Anaplastic Large Cell Lymphoma

Author Affiliations
  • 1Private practice, Leawood, Kansas
JAMA Oncol. 2018;4(10):1434. doi:10.1001/jamaoncol.2018.2616

To the Editor De Boer et al1 calculate a 1:6920 lifetime risk of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) in Dutch patients. The authors report that 82% of affected patients had macrotextured implants and 45% of all implants sold in the Netherlands from 2010 through 2015 were macrotextured (P < .001).1 Despite this significant comparison, de Boer et al1 do not find an association between implant type and BIA-ALCL risk.1 The authors recognize that their study is limited by the fact that almost no smooth implants are inserted in the Netherlands.1

Add or change institution